These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 19098320

  • 1. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [Abstract] [Full Text] [Related]

  • 2. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.
    Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
    [Abstract] [Full Text] [Related]

  • 3. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ, Szabó C.
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [Abstract] [Full Text] [Related]

  • 4. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR, Xu W, Zhang J, Pavlov IA, Shevalye H, Slusher B, Obrosova IG.
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [Abstract] [Full Text] [Related]

  • 5. Na+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosis.
    Lupachyk S, Stavniichuk R, Komissarenko JI, Drel VR, Obrosov AA, El-Remessy AB, Pacher P, Obrosova IG.
    Int J Mol Med; 2012 Jun; 29(6):989-98. PubMed ID: 22407349
    [Abstract] [Full Text] [Related]

  • 6. Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats.
    Byun YS, Kang B, Yoo YS, Joo CK.
    Invest Ophthalmol Vis Sci; 2015 Feb 24; 56(3):1948-55. PubMed ID: 25711635
    [Abstract] [Full Text] [Related]

  • 7. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H, Stavniichuk R, Xu W, Zhang J, Lupachyk S, Maksimchyk Y, Drel VR, Floyd EZ, Slusher B, Obrosova IG.
    Biochem Pharmacol; 2010 Apr 01; 79(7):1007-14. PubMed ID: 19945439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
    Guzyk MM, Tykhomyrov AA, Nedzvetsky VS, Prischepa IV, Grinenko TV, Yanitska LV, Kuchmerovska TM.
    Neurochem Res; 2016 Oct 01; 41(10):2526-2537. PubMed ID: 27255598
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T, Shymanskyy I, Donchenko G, Kuchmerovskyy M, Pakirbaieva L, Klimenko A.
    J Diabetes Complications; 2004 Oct 01; 18(4):198-204. PubMed ID: 15207836
    [Abstract] [Full Text] [Related]

  • 13. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
    Sugawara R, Hikichi T, Kitaya N, Mori F, Nagaoka T, Yoshida A, Szabo C.
    Curr Eye Res; 2004 Jul 01; 29(1):11-6. PubMed ID: 15370362
    [Abstract] [Full Text] [Related]

  • 14. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.
    Drel VR, Pacher P, Stevens MJ, Obrosova IG.
    Free Radic Biol Med; 2006 Apr 15; 40(8):1454-65. PubMed ID: 16631535
    [Abstract] [Full Text] [Related]

  • 15. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
    Chiu J, Xu BY, Chen S, Feng B, Chakrabarti S.
    Can J Physiol Pharmacol; 2008 Jun 15; 86(6):365-72. PubMed ID: 18516100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
    Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA.
    Diabetes; 2005 Dec 15; 54(12):3435-41. PubMed ID: 16306359
    [Abstract] [Full Text] [Related]

  • 20. Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.
    Al-Shabrawey M, Ahmad S, Megyerdi S, Othman A, Baban B, Palenski TL, Shin ES, Gurel Z, Hsu S, Sheibani N.
    Mol Vis; 2012 Dec 15; 18():1895-906. PubMed ID: 22876114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.